Frontiers in Pharmacology (May 2023)
Editorial: Pharmacogenetics and pharmacogenomics in Latin America: ethnic variability, new insights in advances and perspectives: a RELIVAF-CYTED initiative, Volume II
- Andrés López-Cortés,
- Andrés López-Cortés,
- Patricia Esperón,
- Patricia Esperón,
- Matías F. Martínez,
- Matías F. Martínez,
- Matías F. Martínez,
- María A. Redal,
- María A. Redal,
- María A. Redal,
- Alberto Lazarowski,
- Alberto Lazarowski,
- Nelson M. Varela,
- Nelson M. Varela,
- Ismael Lares-Asseff,
- Ismael Lares-Asseff,
- Luis A. Quiñones,
- Luis A. Quiñones,
- Luis A. Quiñones
Affiliations
- Andrés López-Cortés
- Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador
- Andrés López-Cortés
- Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile
- Patricia Esperón
- Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile
- Patricia Esperón
- Molecular Genetics Laboratory, Clinical Biochemistry Department, School of Chemistry, Universidad de la República, Montevideo, Uruguay
- Matías F. Martínez
- Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile
- Matías F. Martínez
- Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile
- Matías F. Martínez
- Department of Pharmaceutical Science and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile
- María A. Redal
- Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile
- María A. Redal
- Genetic Division, Department of Medicine, Faculty of Medicine, Hospital de Clínicas José de San Martín, Buenos Aires University, Buenos Aires, Argentina
- María A. Redal
- Clinical Biochemistry Department, Faculty of Pharmacy and Biochemistry, Institute for Research in Physiopathology and Clinical Biochemistry (INFIBIOC), Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina
- Alberto Lazarowski
- Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile
- Alberto Lazarowski
- Clinical Biochemistry Department, Faculty of Pharmacy and Biochemistry, Institute for Research in Physiopathology and Clinical Biochemistry (INFIBIOC), Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina
- Nelson M. Varela
- Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile
- Nelson M. Varela
- Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile
- Ismael Lares-Asseff
- Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile
- Ismael Lares-Asseff
- Academy of Genomics and Laboratory of Pharmacogenomics and Molecular Biomedicine, Instituto Politécnico Nacional, CIIDIR-Unidad Durango, Durango, Mexico
- Luis A. Quiñones
- Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile
- Luis A. Quiñones
- Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile
- Luis A. Quiñones
- Department of Pharmaceutical Science and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile
- DOI
- https://doi.org/10.3389/fphar.2023.1211712
- Journal volume & issue
-
Vol. 14
Abstract
No abstracts available.Keywords